Advertisements



Boston Scientific"s 25 mm Lotus Valve Wins CE Mark - Analyst Blog

Management at Boston Scientific (BSX) is enthusiastic about the commercial launch of the Lotus Valve system only seven months after its initial launch revealing their commitment to improving therapy modes and patient outcomes. Massachusetts-b.....»»

Category: topSource: zacksJul 16th, 2014

Medtronic begins initial European launch of MiniMed Duo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallJun 3rd, 2014

Horizon Pharma"s (HZNP) CEO Tim Walbert on Q1 2014 Results - Earnings Call Transcript

Horizon Pharma, Inc. (HZNP) Q1 2014 Results Earnings Conference Call May 09, 2014 08:00 AM ET Executives Bob De Vaere - EVP and Chief Financial Officer Tim Walbert - Chairman, President and CEO Tod Smith - EVP and Chief Commercial Officer Analysts.....»»

Category: topSource: seekingalphaMay 9th, 2014

Horizon Pharma Has Significant Growth Potential

By ONeil Trader:Horizon Pharma (HZNP) had a truly transformational year in 2013, and is set to deliver strong revenue growth and achieve non-GAAP profitability in 2014. The company successfully marketed Duexis and Rayos, acquired the rights for Vimovo fro.....»»

Category: topSource: seekingalphaMar 20th, 2014

Buy Horizon Pharma On Upcoming Revenue Growth

By Equity Flux: Introduction Horizon Pharma develops and commercializes products that target arthritis, pain and inflammatory diseases. The company is currently marketing Duexis, Rayos/Lodotra and the newly acquired Vimovo to orthopedic surgeons and rhe.....»»

Category: topSource: seekingalphaMar 5th, 2014

Horizon Pharma Issues Update on Feb. 10-11th FDA Joint Panel Meeting on CV Risk of NSAIDs

Horizon Pharma, Inc., (NASDAQ: HZNP), a commercial stage, specialty pharmaceutical company that markets two gastroprotective nonsteroidal anti-inflammatory drugs (NSAIDs), VIMOVO(R) (naproxen/esomeprazole magnesium) and DUEXIS(R) (ibuprofen and famotidine.....»»

Category: blogSource: benzingaFeb 11th, 2014

Horizon Pharma says Par to withdraw ANDA for generic Rayos

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallNov 22nd, 2013

Volcano Launches Crux Vena Cava Filter - Analyst Blog

Volcano expands Product portfolio with the commercial launch of Crux Vena Cava Filter Volcano Corporation (VOLC) announced the commercial release as well as the initial implantations of the novel device – Crux Vena Cava Filter (VCF). Th.....»»

Category: topSource: zacksNov 14th, 2013

Horizon Pharma Continues Cash Burn And Dilution

By Chimera Research Group: By Patrick Crutcher We last wrote on Horizon Pharma (HZNP) following their FDA approval of RAYOS, but seems not much has changed. However, the stock has risen roughly 60% year to date with no apparent change in fundamentals. W.....»»

Category: topSource: seekingalphaNov 8th, 2013

Horizon Pharma presents newe clinical data on Rayos DR tablets

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallOct 29th, 2013

Horizon Pharma Reports Clinical Data on RAYOS Tablets Which Will Be Presented at American College of Rheumatology Annual Meeting

Horizon Pharma, Inc (NASDAQ: HZNP) today announced that two published abstracts of its approved treatment RAYOS(R) (prednisone) delayed-release tablets will be presented during the American College of Rheumatology (ACR)/Association of Rheumatology Health .....»»

Category: blogSource: benzingaOct 21st, 2013

Lending Club Has Unusual Version of “Peer-to-Peer”

As firm's intention to launch IPO are clear, what is the risk level involved in an investment?Lending Club, the “peer-to-peer” lending company who filed for an initial public offering today, might not be what one might assume, points out Bloom.....»»

Category: blogSource: valuewalkAug 28th, 2014

SpaceX Delaying Commercial Satellite Launch For Two Weeks

SpaceX reviewing launch procedures after test rocket accident last weekPrivately held SpaceX postponed the scheduled Wednesday, August 27th liftoff of a commercial telecommunications satellite in order to undertake a thorough check of all launch systems g.....»»

Category: blogSource: valuewalkAug 27th, 2014

Alibaba"s Results Jump Ahead of IPO

The Chinese e-commerce company posted a jump in profit and revenue for the most recent quarter, weeks before it is expected to launch its hotly anticipated U.S. initial public offering......»»

Category: smallbizSource: wsjAug 27th, 2014

Skystar Bio-Pharma to launch probiotic product for dairy cows by end of FY14

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active trader.....»»

Category: blogSource: theflyonthewallAug 26th, 2014

The 4 Companies Teaming Up For A New Tool To Fight Cancer

A new tool in the fight against cancer is on the horizon. Big pharma and one relatively small company are teaming up to develop a master test that will help doctors pick a combination of drugs tailored to the individual patient’s condition......»»

Category: blogSource: benzingaAug 25th, 2014

Advertising And The Belviq Re-Launch

By Spencer Osborne:July of 2014 marked the "re-launch" of the anti-obesity drug Belviq from Arena Pharmaceuticals (NASDAQ:ARNA) and marketing partner Eisai (OTCPK:ESALY). Belviq had its initial launch in June of 2013 and sales during the first year came i.....»»

Category: topSource: seekingalphaAug 25th, 2014

Elon Musk"s SpaceX Launch Site Gets Big Break

SpaceX, the commercial launch site planned by Elon Musk, has received a decade-long tax break from Cameron County.SpaceX, the commercial launch site planned by Elon Musk, has received a decade-long tax break from Cameron County......»»

Category: topSource: incAug 22nd, 2014

Garmin Introduces New Navigation Devices

Garmin International Inc. announced plans to launch two new Android-based commercial navigation devices......»»

Category: topSource: ttnewsAug 22nd, 2014

Review: BBC America"s "Intruders" Is A Good Series With A Dull Pilot

Pilots are hard, and they often have 42 minutes to hook viewers enough to convince them to come back next week. Sometimes, they work. Many times, they don’t. But when a series moves past its initial episode, it begins to grow in a way that makes it wort.....»»

Category: topSource: forbesAug 20th, 2014